IMPACT OF PROGESTERONE AND ESTRADIOL CONCENTRATION RATIO ON THE DAY OF FINAL OOCYTE MATURATION TRIGGER INJECTION ON PREGNANCY RATE AND OVARIAN HYPERSTIMULATION SYNDROME RISK IN WOMEN UNDERGOING VITRO FERTILIZATION

Concentration Ratio ◽

Vitro Fertilization ◽

Final Oocyte Maturation ◽

Estradiol Concentration

Implementing two strategies to avoid ovarian hyperstimulation syndrome (OHSS): use of GnRH agonists (GnRHa) to trigger final oocyte maturation associated with blastocyst cryopreservation

Fertility and Sterility ◽

10.1016/j.fertnstert.2013.07.244 ◽

2013 ◽

Vol 100 (3) ◽

pp. S517-S518

Author(s):

M.M. Carneiro ◽

A.L.M. Silva ◽

A.M.M. Cota ◽

J.P.J. Caetano

Keyword(s):

Oocyte Maturation ◽

Gnrh Agonists ◽

Final Oocyte Maturation

Final oocyte maturation with two different GnRH agonists in antagonist co-treated cycles at risk of ovarian hyperstimulation syndrome

Reproductive BioMedicine Online ◽

10.1016/j.rbmo.2016.10.004 ◽

2017 ◽

Vol 34 (1) ◽

pp. 5-10 ◽

Cited By ~ 3

Author(s):

Yavuz Emre Şükür ◽

Batuhan Özmen ◽

Elif Didem Özdemir ◽

Mehmet Murat Seval ◽

Erkan Kalafat ◽

...

Keyword(s):

At Risk ◽

Oocyte Maturation ◽

Gnrh Agonists ◽

Final Oocyte Maturation

Recombinant vs. urinary human chorionic gonadotrophin (hCG) for triggering final oocyte maturation in patients at risk for ovarian hyperstimulation syndrome OHSS: a randomized clinical trial

10.26226/morressier.573c1514d462b80296c98c10 ◽

2016 ◽

Author(s):

Georgios Lainas

Keyword(s):

Clinical Trial ◽

At Risk ◽

Randomized Clinical Trial ◽

Oocyte Maturation ◽

Chorionic Gonadotrophin ◽

Human Chorionic Gonadotrophin ◽

Final Oocyte Maturation ◽

Patients At Risk

GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy?

Journal of Assisted Reproduction and Genetics ◽

10.1007/s10815-008-9198-1 ◽

2008 ◽

Vol 25 (2-3) ◽

pp. 63-66 ◽

Cited By ~ 25

Author(s):

S. Kol ◽

I. Solt

Keyword(s):

At Risk ◽

Oocyte Maturation ◽

Gnrh Agonist ◽

Final Oocyte Maturation ◽

Patients At Risk

A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols

Journal of Assisted Reproduction and Genetics ◽

10.1007/s10815-017-1074-4 ◽

2017 ◽

Vol 35 (2) ◽

pp. 297-307

Author(s):

Yanett Anaya ◽

Douglas A. Mata ◽

Joseph Letourneau ◽

Hakan Cakmak ◽

Marcelle I. Cedars ◽

...

Keyword(s):

In Vitro Fertilization ◽

Oocyte Maturation ◽

Chorionic Gonadotropin ◽

Human Chorionic Gonadotropin ◽

Follicle Stimulating Hormone ◽

Vitro Fertilization ◽

Stimulating Hormone

Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy

The Journal of Clinical Endocrinology & Metabolism ◽

10.1210/jc.2015-2332 ◽

2015 ◽

Vol 100 (9) ◽

pp. 3322-3331 ◽

Cited By ~ 67

Author(s):

Ali Abbara ◽

Channa N. Jayasena ◽

Georgios Christopoulos ◽

Shakunthala Narayanaswamy ◽

Chioma Izzi-Engbeaya ◽

...

Keyword(s):

High Risk ◽

In Vitro Fertilization ◽

Oocyte Maturation ◽

Vitro Fertilization

The impact of using gonadotropin-releasing hormone agonist for triggering final oocyte maturation in antagonist-treated intracytoplasmic sperm injection cycles on women at high risk of developing ovarian hyperstimulation syndrome

Evidence Based Womenʼs Health Journal ◽

10.1097/01.ebx.0000482801.97372.5c ◽

2016 ◽

Vol 6 (3) ◽

pp. 85-89

Author(s):

Noura S. Elnassery ◽

Fouad A. Abuhamila

Keyword(s):

High Risk ◽

Oocyte Maturation ◽

Intracytoplasmic Sperm Injection ◽

Gonadotropin Releasing Hormone ◽

Releasing Hormone ◽

Gonadotropin Releasing Hormone Agonist ◽

Final Oocyte Maturation ◽

The Impact

Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting

Fertility and Sterility ◽

10.1016/j.fertnstert.2009.10.034 ◽

2010 ◽

Vol 94 (3) ◽

pp. 1111-1114 ◽

Cited By ~ 29

Author(s):

Andrea J. DiLuigi ◽

Lawrence Engmann ◽

David W. Schmidt ◽

Donald B. Maier ◽

John C. Nulsen ◽

...

Keyword(s):

High Risk ◽

Clinical Outcomes ◽

Oocyte Maturation ◽

Gonadotropin Releasing Hormone ◽

Releasing Hormone ◽

Gonadotropin Releasing Hormone Agonist ◽

Final Oocyte Maturation ◽

Risk Patients

Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a “freeze-all” strategy: a prospective multicentric study

Fertility and Sterility ◽

10.1016/j.fertnstert.2011.01.163 ◽

2011 ◽

Vol 95 (6) ◽

pp. 2029-2033.e1 ◽

Cited By ~ 105

Author(s):

Georg Griesinger ◽

Laura Schultz ◽

Thomas Bauer ◽

Anke Broessner ◽

Thorsten Frambach ◽

...

Keyword(s):

Oocyte Maturation ◽

Gonadotropin Releasing Hormone ◽

Multicentric Study ◽

Releasing Hormone ◽

Gonadotropin Releasing Hormone Agonist ◽

Final Oocyte Maturation ◽

Antagonist Protocol

Author Correction: A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols

Journal of Assisted Reproduction and Genetics ◽

10.1007/s10815-017-1093-1 ◽

2017 ◽

Vol 35 (2) ◽

pp. 309-309 ◽

Cited By ~ 1

Author(s):

Yanett Anaya ◽

Douglas A. Mata ◽

Joseph Letourneau ◽

Hakan Cakmak ◽

Marcelle I. Cedars ◽

...

Keyword(s):

In Vitro Fertilization ◽

Oocyte Maturation ◽

Chorionic Gonadotropin ◽

Human Chorionic Gonadotropin ◽

Follicle Stimulating Hormone ◽

Vitro Fertilization ◽

Stimulating Hormone